IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

76 hedge funds and large institutions have $202M invested in iShares US Pharmaceuticals ETF in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+13
Holders Change %
+20.63%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
23
Reduced
18
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CCMG
1
Clark Capital Management Group
Pennsylvania
$4.84M
2
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$6.38M
3
DS
3
DRW Securities
Illinois
$2.74M
4
VKH
4
Virtu KCG Holdings
New York
$1.91M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$3.23M

Top Sellers

1
BCI
1
Brinker Capital Investments
Pennsylvania
$8.33M
2
PAMU
2
Pictet Asset Management (UK)
United Kingdom
$2.67M
3
Morgan Stanley
3
Morgan Stanley
New York
$33.6M
4
Bank of America
4
Bank of America
North Carolina
$24.6M
5
SG Americas Securities
5
SG Americas Securities
New York
$170K
Name Holding Trade Value Shares
Change 		Shares
Change %
GI
76
Gradient Investments
Minnesota
$5K – – –
BC
77
Bartlett & Co
Ohio
$4K – – –
CCM
78
Condor Capital Management
New Jersey
– -$261K -7,368 Closed
BRWA
79
B. Riley Wealth Advisors
Florida
– -$161K -4,530 Closed
SF
80
Synovus Financial
Georgia
– -$67K -1,893 Closed
1 2 3
4